Plasmidfactory obtained worldwide license from DKFZ for manufacture of pDG helper/packaging vectors
|| Print ||
|Thursday, 08 February 2007 00:00 (UTC + 1)|
PlasmidFactory (Bielefeld, Germany), a leading contract manufacturer for plasmid DNA, has obtained a worldwide license from the German Cancer Research Center DKFZ (Heidelberg, Germany) for the manufacture and the marketing of the pDG helper/packaging vector series used for adeno-associated virus (AAV) production.
The license agreement extends to multiple vector serotypes such as pDG, pDM, and pDP1rs to pDP6rs as well as the pDG without heparin binding motive and other helper/packaging vectors. PlasmidFactory, who manufactures these vectors in stock for immediate shipment, is furthermore allowed to issue sub-licenses to other distributors to assure efficient and worldwide sales and distribution.
Cotransfection of cells with pDG and AAV vector plasmid is sufficient for production of infectious recombinant AAV, since the pDG vectors contain all AAV and adenovirus functions required for amplification and packaging of AAV vector plasmids. For optimal co-transfection results homogenous supercoiled ccc-plasmid DNA is a prerequisite, which is manufactured up to GMP Grade Quality by PlasmidFactory and characterized using the capillary gel electrophoresis (CGE) technology.
Over the past decade, AAV-based vectors have emerged as promising candidates for gene therapeutic applications. AAV is a naturally occurring virus that is not associated with any disease in humans and that is therefore used to ferry helpful genes into target cells.
About PlasmidFactory - www.plasmidfactory.com
PlasmidFactory is a contract manufacturer for plasmid DNA from research scale (e.g. 10 mg) up to industrial scale for R&D, veterinary or human DNA vaccination, gene therapy, virus production, drug delivery, or tumor therapy. The plasmid DNA is manufactured from Research Grade up to GMP-Grade quality without using any animal-derived components.
Besides the service production of plasmid DNA, the company offers on-stock plasmids for reporter gene vectors, mock transfections, and pDG vectors for AAV virus production.
For further information about the company:
Dr. Martin Schleef